Cargando…

HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy

Advanced studies have shown a biological correlation between hepatitis B virus (HBV) and B-cell lymphoma, especially diffuse large B-cell lymphoma (DLBCL). Patients with DLBCL infected with HBV (HBV-associated DLBCL) are clinically characterized by an advanced clinical stage, poor response to front-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Xin, Young, Ken H., Bai, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360167/ https://www.ncbi.nlm.nih.gov/pubmed/37483605 http://dx.doi.org/10.3389/fimmu.2023.1216610

Ejemplares similares

Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients
por: Shi, Qing, et al.
Publicado: (2017)

CD5 and CD43 Expression are Associate with Poor Prognosis in DLBCL Patients
por: Huang, Hui, et al.
Publicado: (2018)

Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis
por: Alsaadi, Mohammed, et al.
Publicado: (2021)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023)

Gastric DLBCL clonal evolution as function of patient age
por: Iosselevitch, Irina, et al.
Publicado: (2022)

Editorial: Advances in Pathogenesis and Therapies of Gout
por: Duan, Lihua, et al.
Publicado: (2022)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL
por: Jeyakumar, Nikeshan, et al.
Publicado: (2022)

The immune checkpoint expression in the tumor immune microenvironment of DLBCL: Clinicopathologic features and prognosis
por: Ma, Jiajia, et al.
Publicado: (2022)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

B10 Cells Are Associated With Clinical Prognosis During Adult Symptomatic Acute HBV Infection
por: Liu, Yali, et al.
Publicado: (2022)

Editorial: Autoimmune Vasculitis - Advances in Pathogenesis and Therapies
por: Ooi, Joshua D., et al.
Publicado: (2021)

Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients
por: Chang, Zhenglin, et al.
Publicado: (2022)

Lymphomas in cartilage-hair hypoplasia – A case series of 16 patients reveals advanced stage DLBCL as the most common form
por: Kukkola, Hanna-Leena, et al.
Publicado: (2022)

CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors
por: Chen, Yu, et al.
Publicado: (2020)

Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
por: Du, Yanqin, et al.
Publicado: (2022)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

Editorial: Pathogenesis, immune escape, prognosis, and novel management of lymphoid proliferative disorders
por: Sang, Wei
Publicado: (2022)

Editorial: Advances in Pathogenesis, Etiology, and Therapies for Ankylosing Spondylitis
por: Chen, Chih-Wei, et al.
Publicado: (2021)

ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer
por: Shen, Xiaonan, et al.
Publicado: (2022)

PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma
por: Wang, Jinxiang, et al.
Publicado: (2023)

Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy
por: Bozward, Amber G., et al.
Publicado: (2021)

Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
por: Yang, Shanshan, et al.
Publicado: (2022)

Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle
por: Tripodo, Claudio, et al.
Publicado: (2023)

Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
por: Geng, Hongzhi, et al.
Publicado: (2023)

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection
por: Zhang, Lu, et al.
Publicado: (2023)

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
por: Wang, Ying, et al.
Publicado: (2021)

Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
por: Song, Junquan, et al.
Publicado: (2022)

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
por: Lin, Wei, et al.
Publicado: (2021)

Editorial: Advances in understanding the pathogenesis of and designing therapies for connective tissue disease-associated interstitial lung disease
por: Duan, Lihua, et al.
Publicado: (2023)

Genomic analysis quantifies pyroptosis in the immune microenvironment of HBV-related hepatocellular carcinoma
por: Li, Jiarui, et al.
Publicado: (2022)

Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement
por: Saldi, Simonetta, et al.
Publicado: (2022)

Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies
por: Vuerich, Marta, et al.
Publicado: (2021)

Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses
por: Gillgrass, Amy, et al.
Publicado: (2021)

Role of NFAT5 in the Immune System and Pathogenesis of Autoimmune Diseases
por: Lee, Naeun, et al.
Publicado: (2019)

Can G-quadruplex become a promising target in HBV therapy?
por: Teng, Ye, et al.
Publicado: (2022)

Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis
por: Mahmud, Shawn A., et al.
Publicado: (2019)

Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
por: Li, Ping, et al.
Publicado: (2021)

HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice
por: Zhang, Wendi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33ng9ij249r8uh92kvd74fdcmb